{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34826382",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "11",
        "Day": "23"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/S1473-3099(21)00697-6",
      "S1473-3099(21)00697-6"
    ],
    "Journal": {
      "ISSN": "1474-4457",
      "JournalIssue": {
        "Volume": "22",
        "Issue": "3",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar"
        }
      },
      "Title": "The Lancet. Infectious diseases",
      "ISOAbbreviation": "Lancet Infect Dis"
    },
    "ArticleTitle": "SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines.",
    "Pagination": {
      "StartPage": "301",
      "EndPage": "302",
      "MedlinePgn": "301-302"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Translational Health Science and Technology Institute, Faridabad, India."
          }
        ],
        "LastName": "Thiruvengadam",
        "ForeName": "Ramachandran",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Translational Health Science and Technology Institute, Faridabad, India."
          }
        ],
        "LastName": "Binayke",
        "ForeName": "Akshay",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Translational Health Science and Technology Institute, Faridabad, India. Electronic address: aawasthi@thsti.res.in."
          }
        ],
        "LastName": "Awasthi",
        "ForeName": "Amit",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Lancet Infect Dis",
    "NlmUniqueID": "101130150",
    "ISSNLinking": "1473-3099"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "COVID-19 Vaccines"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vaccines"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Lancet Infect Dis. 2022 Mar;22(3):349-356",
      "PMID": "34826383"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Vaccines"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Vaccines"
    }
  ],
  "CoiStatement": "We declare no competing interests."
}